Vancomycin-resistant enterococci Journal Article

  


Authors: Henning, K.; Brown, A. E.
Article Title: Vancomycin-resistant enterococci
Abstract: The emergence and proliferation of enterococci resistant to all commonly used antimicrobials, especially vancomycin, has serious implications for immunosuppressed and debilitated patients, including cancer patients. There is currently no clinically proven therapy that is effective against enterococci resistant to ampicillin, aminoglycosides, and vancomycin. Careful susceptibility testing in the clinical laboratory is crucial in guiding alternative therapy. Aggressive infection control measures and prudent use of vancomycin are vital to control the spread of vancomycin-resistant enterococci.
Keywords: antibiotic agent; review; drug resistance; antibiotic resistance; high risk population; enterococcus; vancomycin; doxycycline; cotrimoxazole; quinoline derived antiinfective agent; rifampicin; bacterial infection; ampicillin; teicoplanin; minimum inhibitory concentration; aminoglycoside antibiotic agent; chloramphenicol; tetracycline derivative; cancer; human
Journal Title: Infections in Medicine
Volume: 12
Issue: 1
ISSN: 0749-6524
Publisher: SCP Communications  
Date Published: 1995-01-01
Start Page: 13
End Page: 14, 17
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028890589&partnerID=40&md5=e7d475165bf0b3e38e0edd8beb836abb
Notes: Review -- Export Date: 28 August 2018 -- Source: Scopus